GamaMabs Pharma Board of Directors is composed of :
- Prof. Thierry HERCEND, Chairman of the Board, Venture Partner, Edmond de Rothschild Investment Partners ;
- Mr Philippe BOUCHERON, Innobio, BPI Life Science Director ;
- Mr Gilles NOBECOURT, Partner, Edmond de Rothschild Investment Partners ;
- Mr Benjamin MERY, Financial Operations Director LFB ;
- Dr François THOMAS, Independent Director ;
- Dr Martine J. GEORGE, Independent Director ;
- Mr Stéphane DEGOVE, CEO GamaMabs Pharma ;
- Dr Jean-François PROST, Vice-President R&D and Strategy GamaMabs Pharma ;
- Mr Jean-Michel PETIT, IRDINOV Health Franchise Director.
